Patents by Inventor Haruyasu Yamaguchi

Haruyasu Yamaguchi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Monoclonal antibody and use thereof
    Patent number: 8338379
    Abstract: An antibody capable of recognizing amyloid ? while not recognizing amyloid ? precursor proteins, and a method for using the same. A monoclonal antibody characterized by being capable of recognizing the N-terminus peptide of amyloid ? while not recognizing amyloid ? precursor proteins, an amyloid ? assay kit, a therapeutic agent of Alzheimer's disease, and a method for treating Alzheimer's disease using the monoclonal antibody.
    Type: Grant
    Filed: September 23, 2010
    Date of Patent: December 25, 2012
    Assignee: Intellect Neurosciences, Inc.
    Inventors: Haruyasu Yamaguchi, Noriaki Kinoshita, Masahiro Maeda, Yuko Horikoshi
  • MARKER PEPTIDE FOR ALZHEIMER'S DISEASE
    Publication number: 20110014635
    Abstract: To provide a peptide obtainable by cleaving an N-terminal region and a C-terminal region of Alcadein ?, Alcadein ?, or Alcadein ?; and capable of being a diagnostic marker for Alzheimer's disease. It is possible to detect Alzheimer's disease at an early stage without burdening subjects to be tested by using the peptide as a diagnostic marker.
    Type: Application
    Filed: August 20, 2010
    Publication date: January 20, 2011
    Inventors: Toshiharu SUZUKI, Yoichi Araki, Naomi Miyagi, Haruyasu Yamaguchi, Masaki Nishimura, Kazuo Yamamoto
  • MONOCLONAL ANTIBODY AND USE THEREOF
    Publication number: 20110008339
    Abstract: An antibody capable of recognizing amyloid ? while not recognizing amyloid ? precursor proteins, and a method for using the same. A monoclonal antibody characterized by being capable of recognizing the N-terminus peptide of amyloid ? while not recognizing amyloid ? precursor proteins, an amyloid ? assay kit, a therapeutic agent of Alzheimer's disease, and a method for treating Alzheimer's disease using the monoclonal antibody.
    Type: Application
    Filed: September 23, 2010
    Publication date: January 13, 2011
    Applicant: INTELLECT NEUROSCIENCES INC.
    Inventors: Haruyasu Yamaguchi, Noriaki Kinoshita, Masahiro Maeda, Yuko Horikoshi
  • Marker peptide for alzheimer's disease
    Patent number: 7807777
    Abstract: To provide a peptide obtainable by cleaving an N-terminal region and a C-terminal region of Alcadein ?, Alcadein ?, or Alcadein ?; and capable of being a diagnostic marker for Alzheimer's disease. It is possible to detect Alzheimer's disease at an early stage without burdening subjects to be tested by using the peptide as a diagnostic marker.
    Type: Grant
    Filed: November 1, 2004
    Date of Patent: October 5, 2010
    Assignee: Immuno-Biological Laboratories Co., Ltd.
    Inventors: Toshiharu Suzuki, Yoichi Araki, Naomi Miyagi, Haruyasu Yamaguchi, Masaki Nishimura, Kazuo Yamamoto
  • Monoclonal antibodies and use thereof
    Patent number: 7807157
    Abstract: An antibody capable of recognizing amyloid ? while not recognizing amyloid ? precursor proteins, and a method for using the same. A monoclonal antibody characterized by being capable of recognizing the N-terminus peptide of amyloid ? while not recognizing amyloid ? precursor proteins, an amyloid ? assay kit, a therapeutic agent of Alzheimer's disease, and a method for treating Alzheimer's disease using the monoclonal antibody.
    Type: Grant
    Filed: September 16, 2004
    Date of Patent: October 5, 2010
    Assignee: Intellect Neurosciences Inc.
    Inventors: Haruyasu Yamaguchi, Noriaki Kinoshita, Masahiro Maeda, Yuko Horikoshi
  • Monoclonal Antibody And Use Thereof
    Publication number: 20080025988
    Abstract: An antibody capable of recognizing amyloid ? while not recognizing amyloid ? precursor proteins, and a method for using the same. A monoclonal antibody characterized by being capable of recognizing the N-terminus peptide of amyloid ? while not recognizing amyloid ? precursor proteins, an amyloid ? assay kit, a therapeutic agent of Alzheimer's disease, and a method for treating Alzheimer's disease using the monoclonal antibody.
    Type: Application
    Filed: September 16, 2004
    Publication date: January 31, 2008
    Applicant: IMMUNO-BIOLOGICAL LABORATORIES CO., LTD.
    Inventors: Haruyasu Yamaguchi, Noriaki Kinoshita, Masahiro Maeda, Yuko Horikoshi
  • Marker peptide for alzheimer's disease
    Publication number: 20070111252
    Abstract: To provide a peptide obtainable by cleaving an N-terminal region and a C-terminal region of Alcadein ?, Alcadein ?, or Alcadein ?; and capable of being a diagnostic marker for Alzheimer's disease. It is possible to detect Alzheimer's disease at an early stage without burdening subjects to be tested by using the peptide as a diagnostic marker.
    Type: Application
    Filed: November 1, 2004
    Publication date: May 17, 2007
    Applicant: Toshiharu Suzuki
    Inventors: Toshiharu Suzuki, Yoichi Araki, Naomi Miyagi, Haruyasu Yamaguchi, Masaki Nishimura, Kazuo Yamamoto